Multifocal Small Bowel Carcinoid: Evaluation by 68Ga-DOTATATE PET

Michael Clark, Mark Nathan, Stephen Broski

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Carcinoid is a subtype of neuroendocrine tumor, a rare group of tumors that are known to express somatostatin receptor 2. 68Ga-DOTATATE is a somatostatin analog that is specific for somatostatin receptor 2 and therefore allows visualization of neuroendocrine tumors. We present 2 cases of primary multifocal small bowel carcinoid evaluated using 68Ga-DOTATATE PET/CT, along with contrast-enhanced CT corollary findings. Given the increased sensitivity of 68Ga-DOTATATE PET/CT compared with CT and 111In-octreotide scintigraphy, we expect multifocal carcinoid to become increasingly recognized.

Original languageEnglish (US)
Pages (from-to)e308-e310
JournalClinical nuclear medicine
Issue number4
StatePublished - Apr 1 2019


  • carcinoid
  • neuroendocrine
  • somatostatin receptor

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Multifocal Small Bowel Carcinoid: Evaluation by 68Ga-DOTATATE PET'. Together they form a unique fingerprint.

Cite this